The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 1 to 10 of 418 resources
-
United Kingdom drug situation: Focal Point annual report 2017
UK Reports & Research PDF -
Taking the initiative: how England is eliminating hepatitis C
This report explores the unprecedented hepatitis C elimination programme developed since 2019 between NHS England, pharmaceutical industry providers, voluntary sector bodies and other partners, and profiles ‘elimination initiatives’ that have been developed in different parts of the country and wider health and care system as a result.England 21 Feb 2023 Reports & Research PDF -
A Census of Medical Workforce & Infrastructure for Liver Disease Strategy: Summary of Findings
As part of the National Liver Disease Strategy (NLDS), this document summarises the findings of a Census of the Medical Workforce (Consultant Gastroenterologists and Hepatologists). The census was undertaken with the aim of assessing the current capacity and infrastructure for delivery of Liver services in England, to identify which secondary care pathways already exist for referral and management, to understand how the current secondary care services relate to burden of disease, and to assess future training needs and capacity for liver services.England 2011 Reports & Research, Strategy & Planning PDF -
A glossary of contested terms in substance use
This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.UK 07 Oct 2020 Training, Reports & Research PDF -
A Time to Act: Improving Liver Health and Outcomes in Liver Disease
This document reviews the current landscape of UK liver disease and advises the Department of Health on ways to improve liver services and the outcomes of liver disease in the UK. It stresses the fact that radical change in the profile of the disease is achievable, and includes recommendations on cost-effective and high quality management of liver disease and liver services, the establishment of training frameworks and the setting of clinical standards, quality metrics and guidelines for the monitoring and assessment of local services.UK 2009 Reports & Research, Strategy & Planning PDF -
Access and Uptake of Direct Acting Antiviral Medicines in the UK and selected European countries
This report, produced by IMS Health and commissioned by the Association of the British Pharmaceutical Industry (ABPI), provides information related to the uptake of Direct Acting Antiviral treatments (DAAs) over the last five years, to June 2016. The intention of the report is to benchmark the UK – in relation to patient access to these medicines – compared with other European countries. It finds that there have been significant variances in the ability of patients to access these medicines.UK Feb 2017 Reports & Research PDF -
Action Plan for the Prevention, Management and Control of Hepatitis C in Northern Ireland
The actions set out in this report form the core of a plan to address hepatitis C in Northern Ireland for the period 2006-2008. Its aim is to achieve a reduction in the transmission of hepatitis C in Northern Ireland and to ensure that people with hepatitis C infection are identified and receive high quality, evidence-based, patient-focused treatment and care.Northern Ireland Jan 2007 Reports & Research, Strategy & Planning PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Addressing hepatitis C in prisons and other places of detention
A report from The Hepatitis C Trust providing recommendations for hepatitis C healthcare service in prisons and other detention settings in the UK.
UK May 2013 Reports & Research PDF -
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
This report, published by the Lancet Commission on Liver Disease, addresses the liver disease crisis in the UK. The report contains ten recommendations for improving liver care and reducing premature mortality rates caused by liver disease. These recommendations include the eradication of chronic hepatitis C infections in the UK by 2030, and increasing the provision of medical and nursing training in hepatology.UK, England, Northern Ireland, Scotland, Wales Dec 2014 Reports & Research PDF